Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Longtai Biological Technology is a biotechnology company specializing in the research, development, and manufacturing of rapid diagnostic reagents and instruments. The company focuses on Point-of-Care Testing (POCT) solutions for both human health and animal disease detection. Their product portfolio includes lateral flow assays for infectious diseases, including COVID-19, influenza, and various veterinary pathogens like African Swine Fever. Longtai Biological operates high-standard manufacturing facilities and provides products to global markets, emphasizing rapid, accurate, and user-friendly diagnostic tools. The company is recognized as a high-tech enterprise and maintains rigorous quality standards such as ISO 13485.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LongTai Biological.